Hereditary angioedema agents

Takhzyro 300 mg/2 mL (150 mg/mL) single-dose vial Images

Generic Name: lanadelumab

This medication has been identified as Takhzyro 300 mg/2 mL (150 mg/mL) single-dose vial. It is supplied by Takeda Pharmaceutical Company Limited.

Takhzyro is used in the treatment of Hereditary Angioedema and belongs to the drug class hereditary angioedema agents. Takhzyro 300 mg/2 mL (150 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).

Images

Takhzyro (Lanadelumab-flyo [ lan-a-del-ue-mab ])-medicine-300 mg/2 mL (150 mg/mL) single-dose vial

Takhzyro
Generic Name: lanadelumab-flyo [ lan-a-del-ue-mab ]
Imprint: medicine
Strength: 300 mg/2 mL (150 mg/mL) single-dose vial
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Hereditary angioedema agents
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 47783-0644
Inactive Ingredients:
Latest News
Related Drugs